课题基金 / 基金详情

BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS

BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
血液替代品——分子和生理方面
批准号:
2519336
负责人:
Robert M Winslow
金额:
$83.63万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-01 至 1998-08-31

项目摘要

项目成果

Robert M Winslow的其他基金

相似基金

相关文献

中文摘要
翻译
这个计划的假设是细胞自由
英文摘要
The hypothesis underlying this Program Project is that cell free hemoglobin, suitably modified by structural engineering, will be safe and effective therapy in many clinical situations where red blood cells are indicated. The main goal of the Program Project is to understand the physiological consequences and clinical potential of replacement of red blood cells in the circulation with acellular blood substitutes. Expertise in design, production and testing of new solutions, with academic expertise in several key areas of biochemistry, physiology, molecular biology and clinical medicine will be brought together under this Program Project to focus on specific problems of large scale infusions of acellular red cell substitutes, while simultaneously exploiting emerging technology to shed new light on basic physiological and biochemical problems. The elements of the Program Project reflect the interests of the UCSD faculty, rather than a comprehensive approach to development of blood substitutes. However, the expertise is broad and deep, and nearly all relevant areas will be studied. Core A will coordinate activities of the component projects and cores, manage budget, purchasing, scheduling of meetings and seminars, and provide basic secretarial support. Core B will produce or obtain materials representing various classes of products under development for investigation by the various projects, including both hemoglobin- and perflurocarbon-based oxygen carries; some will be produced in the Program Project, and others will be obtained from other laboratories. The in vitro ligand binding, stability and toxicity will be related to protein structure in Project 1, and the effects on the microcirculation will be studied in Project 2, the heart in Project 3, the kidney in Project 4. Data obtained in these projects will be used in Project 1 for the design of new chemically modified or (by collaboration) mutant derivatives of hemoglobin using computer visualization techniques in Project 1. Each project will have advisors from the UCSD faculty. An executive committee made up of the principal investigators from each project and core that has met monthly for the last year will form the nucleus of a group and will continue to share data, results, and plans for future studies. Internal and external advisory groups of outstanding scientists will be appointed to provide expertise in related fields.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing?
αα交联血红蛋白:临床前测试是否预测失败?
DOI: 10.1159/000031200
发表时间: 2000
期刊: Vox sanguinis
影响因子: 2.7
作者: [Winslow,RM]
通讯作者: Winslow,RM
Examples of chemical modification and recombinant DNA approaches with hemoglobin.
使用血红蛋白进行化学修饰和重组 DNA 方法的示例。
DOI: 10.1016/s1246-7820(96)80026-7
发表时间: 1996
期刊: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
影响因子: --
作者: [Manning,JM]
通讯作者: Manning,JM
Subunit dissociations in natural and recombinant hemoglobins.
天然和重组血红蛋白中的亚基解离。
DOI: 10.1002/pro.5560050423
发表时间: 1996
期刊: Protein science : a publication of the Protein Society.
影响因子: --
作者: [Manning,LR, Jenkins,WT, Hess,JR, Vandegriff,K, Winslow,RM, Manning,JM]
通讯作者: Manning,JM
Potential role of luminal potassium in tubuloglomerular feedback.
管腔钾在肾小管肾小球反馈中的潜在作用。
DOI: 10.1681/asn.v8121831
发表时间: 1997
期刊: Journal of the American Society of Nephrology : JASN
影响因子: --
作者: [Vallon,V, Osswald,H, Blantz,RC, Thomson,S]
通讯作者: Thomson,S
30
    OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
    • 批准号:
      6080433
    • 项目类别:
    • 资助金额:
      $35.48万
    • 财政年份:
      1999
    • 负责人:
      Robert M Winslow
    • 依托单位:
    OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
    • 批准号:
      6184925
    • 项目类别:
    • 资助金额:
      $33.89万
    • 财政年份:
      1999
    • 负责人:
      Robert M Winslow
    • 依托单位:
    OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
    • 批准号:
      6537758
    • 项目类别:
    • 资助金额:
      $35.42万
    • 财政年份:
      1999
    • 负责人:
      Robert M Winslow
    • 依托单位:
    OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
    • 批准号:
      6390672
    • 项目类别:
    • 资助金额:
      $34.98万
    • 财政年份:
      1999
    • 负责人:
      Robert M Winslow
    • 依托单位:
    海外基金